In psoriasis, A3 adenosine receptors represent a new predictive marker as they are known to be overexpressed in the PBMCs of patients with autoimmune inflammatory conditions, e.g., of, RA, and Crohn’s disease. The gene discussed is ADORA3; the disease is rheumatoid arthritis.